| CNPAX | MGFYX | CNPAX / MGFYX | |
| Total Expense Ratio | 0.77 | 1.13 | 68% |
| Annual Report Gross Expense Ratio | 0.77 | 1.13 | 68% |
| Fund Existence | 24 years | 21 years | - |
| Gain YTD | 21.203 | 15.344 | 138% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 165B | 155M | 106,452% |
| Annual Yield % from dividends | 0.45 | 0.00 | - |
| Returns for 1 year | 14.57 | -0.73 | -2,000% |
| Returns for 3 years | 51.76 | -9.32 | -555% |
| Returns for 5 years | 34.72 | -33.01 | -105% |
| Returns for 10 years | 109.86 | -22.89 | -480% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHPAX | 21.76 | 0.04 | +0.18% |
| Saratoga Health & Biotechnology A | |||
| JBAFX | 32.73 | 0.05 | +0.15% |
| JHancock Balanced R4 | |||
| HRCCX | 34.07 | 0.02 | +0.06% |
| Carillon ClariVest Capital Apprec C | |||
| HOOTX | 32.24 | 0.02 | +0.06% |
| Hartford Schroders US Small Cap Opps R5 | |||
| FASPX | 48.93 | N/A | N/A |
| Fidelity Advisor Value Strategies M | |||